Normal Saline Flushes at 12 vs 24 Hours Intervals for Maintaining Peripheral Intravenous Catheters Patency
Randomized Controlled Trial to Evaluate the Efficacy of Normal Saline Flushes at 12 and 24 Hours Intervals in Maintaining Peripheral Intravenous Catheters Patency
1 other identifier
interventional
400
1 country
1
Brief Summary
Children admitted in a ward often require a peripheral intravenous catheter to provide access for administration of medications, nutrients, fluids, blood products. Vascular access in children is a frequent and stressful procedure that should be performed as infrequently as possible in order to reduce the child's pain experience and the child's and family's level of distress. The maintenance of patency of indwelling catheters is therefore relevant to minimize need for replacement and children discomfort. Recent studies investigated the most effective and safe method of maintaining peripheral intravenous lock (peripheral IVL) in children. Most of these studies focused primary on the use of heparin versus saline flushes, showing similar efficacy of the two approaches. To the best of the investigators knowledge no study addressed the issue of the optimal flushing frequency of normal saline . The aim of this study was to evaluate the efficacy of normal saline flushes, at 12 and 24 hours intervals.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for phase_3 pain
Started Jul 2011
Typical duration for phase_3 pain
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
July 1, 2011
CompletedPrimary Completion
Last participant's last visit for primary outcome
September 1, 2013
CompletedStudy Completion
Last participant's last visit for all outcomes
September 1, 2013
CompletedFirst Submitted
Initial submission to the registry
August 12, 2014
CompletedFirst Posted
Study publicly available on registry
August 20, 2014
CompletedAugust 20, 2014
August 1, 2014
2.2 years
August 12, 2014
August 19, 2014
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Number of participants with peripheral intravenous catheter patency
Patency was defined as the possibility of flushing the cannula with a 3 ml Becton Dickinson syringe filled with 3 ml of normal saline in less than 20 seconds without resistance at infusion, pain or erythema
Until catheter use (i.e. drug infusion) or removal (catether related complication or no further need of use), with an expected avarage of 48 hours
Secondary Outcomes (4)
Number of participants with blood extravasation
Until catheter use (i.e. drug infusion) or removal (catether related complication or no further need of use), with an expected avarage of 48 hours
Number of participants with pain
Until catheter use (i.e. drug infusion) or removal (catether related complication or no further need of use), with an expected avarage of 48 hours
Number of participants with skin redness
Until catheter use (i.e. drug infusion) or removal (catether related complication or no further need of use), with an expected avarage of 48 hours
Number of participants with swelling
Until catheter use (i.e. drug infusion) or removal (catether related complication or no further need of use), with an expected avarage of 48 hours
Study Arms (2)
Flushing every 24 hours
EXPERIMENTALFlushing with positive pressure with normal saline every 24 hours
Flushing every 12 hours
ACTIVE COMPARATORFlushing with positive pressure with normal saline every 12 hours
Interventions
Placement of a sterile plug (MicroClave ICU Medica, a neutral displacement connector) on the needle cannula and flushing with positive pressure with saline solution (BD PosiFlush XS Syringes, filled with 3 ml of saline)
Eligibility Criteria
You may qualify if:
- age between 1 and 17 years
- peripheral intravenous catheter 22 G or 24 G
- need to maintain the access for at least 24 hours without infusion
You may not qualify if:
- need for continuous infusion therapy
- programmed therapy
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Emergency Department, IRCCS Burlo Garofolo
Trieste, Friuli Venezia Giulia, 34137, Italy
Related Publications (1)
Schreiber S, Zanchi C, Ronfani L, Delise A, Corbelli A, Bortoluzzi R, Taddio A, Barbi E. Normal saline flushes performed once daily maintain peripheral intravenous catheter patency: a randomised controlled trial. Arch Dis Child. 2015 Jul;100(7):700-3. doi: 10.1136/archdischild-2014-307478. Epub 2015 Jan 14.
PMID: 25589559DERIVED
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Study Officials
- STUDY CHAIR
Egidio Barbi, MD
IRCCS Burlo Garofolo, Trieste, Italy
- STUDY DIRECTOR
Silvana Schreiber, RN
IRCCS Burlo Garofolo, Trieste, Italy
Study Design
- Study Type
- interventional
- Phase
- phase 3
- Allocation
- RANDOMIZED
- Masking
- NONE
- Purpose
- SUPPORTIVE CARE
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- MD, PhD
Study Record Dates
First Submitted
August 12, 2014
First Posted
August 20, 2014
Study Start
July 1, 2011
Primary Completion
September 1, 2013
Study Completion
September 1, 2013
Last Updated
August 20, 2014
Record last verified: 2014-08